16 November 2023
Technology and innovation
Large language models are changing the way we carry out scientific data curation, annotation, and research, setting the stage for a more efficient understanding of scientific literature
2023
technology-and-innovation
21 September 2023
Announcements, Lab Matters, People & Perspectives
David Hulcoop discusses how his experience bridging organisational cultures will help address critical challenges in drug discovery and target selection at Open Targets.
2023
announcementslab-matterspeople-perspectives
12 July 2023
Announcements, EMBL Announcements, Lab Matters
Construction begins on EMBL-EBI's new building named after Janet Thornton.
2023
announcementsembl-announcementslab-matters
5 July 2023
Announcements, EMBL Announcements
Coming from a pharmaceutical industry background, David Hulcoop is set to take over as Executive Director of the public-private partnership Open Targets.
2023
announcementsembl-announcements
2 June 2023
Science, Science & Technology, Technology and innovation
A new tool for the interpretation of missense variation in humans – ProtVar – will help enable drug discovery.
2023
sciencescience-technologytechnology-and-innovation
27 February 2023
Research highlights, Science
Researchers create a network of interacting proteins – or interactome – to aid drug discovery.
2023
research-highlightsscience
26 January 2023
Science, Science & Technology, Technology and innovation
Open Targets is using artificial intelligence and machine learning to identify and prioritise drug targets.
2023
sciencescience-technologytechnology-and-innovation
11 November 2022
Announcements, Science
Open Targets announces that Genentech will become the seventh partner in the drug discovery and validation consortium.
2022
announcementsscience
10 February 2022
Announcements, Connections, Science
Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
2022
announcementsconnectionsscience
19 October 2021
Lab Matters, People & Perspectives
Ian Dunham walks us through his career so far including working on the human genome project, seeing his work on the cover of Nature and his current role as Director of Open Targets.
2021
lab-matterspeople-perspectives
21 July 2021
Science, Science & Technology
Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
2021
sciencescience-technology
1 July 2020
Lab Matters, People & Perspectives
Open Targets welcomes new Informatics Science Director
2020
lab-matterspeople-perspectives
10 July 2019
Science, Science & Technology
How computer processing of human language is harnessed by EMBL scientists
2019
sciencescience-technology
8 July 2019
Lab Matters
Reflecting on 20 years of EMBLEM
23 January 2019
Lab Matters, People & Perspectives
New director drives drug discovery partnership forward
2019
lab-matterspeople-perspectives
No matching posts found